Medium Term Stocks to Buy in November 2026: 5 Names on the Watchlist

The medium term stocks to buy in November 2026 start with five listed names: Paradeep Phosphates, SRF, Time Technoplast, KEI Industries and Rainbow Children's Medicare. Medium term stocks are shares investors hold for roughly six months to two years, backed by earnings that are growing at a steady pace.

This article ranks none of them as a sure thing. It lays out the numbers each company has reported, how the shares are priced today and what an investor should check before adding any of these medium term stocks to buy to a portfolio. All prices are NSE closing prices of 3 November 2026, and financials come from company filings.

Click Here – Get Free Investment Predictions

Which Are the Best Medium Term Stocks to Buy in November 2026?

The best medium term stocks to buy in November 2026 for a watchlist are Paradeep Phosphates, SRF, Time Technoplast, KEI Industries and Rainbow Children's Medicare. They were picked because each has complete reported financials, profit in the latest quarter and an NSE listing. The table puts their market data side by side.

Company	CMP (Rs)	Market Cap	P/E	ROE	Dividend Yield
Paradeep Phosphates	133.85	Rs 14,337 crore	13.38	14.69%	1.09%
SRF	2,429	Rs 69,630 crore	30.50	14.92%	0.38%
Time Technoplast	166.50	Rs 8,031 crore	16.12	11.46%	0.92%
KEI Industries	3,881	Rs 36,843 crore	34.90	14.66%	0.12%
Rainbow Children's Medicare	1,246	Rs 12,168 crore	41.92	16.89%	0.29%

On valuation, Paradeep Phosphates, Time Technoplast, KEI Industries and Rainbow Children's Medicare trade below the industry P/E; SRF sits close to it. Valuation is the first filter for any medium term stocks to buy list, and it is covered again in the risk section.

Why These Medium Term Stocks to Buy Are in Focus

In this list, latest-quarter net profit grew between roughly 16% and 31% year on year, and full-year FY26 profit grew by 15% or more for every company. The list covers a phosphate fertiliser maker, a speciality chemicals and packaging films company, a polymer products maker, a cables maker and a paediatric hospital chain. Investors comparing the best medium term stocks in India usually check whether growth looks steady across several quarters and whether the valuation leaves room for the shares to grow.

Paradeep Phosphates: The Phosphate Fertiliser Producer Among Medium Term Stocks to Buy

Paradeep Phosphates is a DAP and NPK fertiliser producer based in eastern India. At Rs 133.85, the stock has a market capitalisation of Rs 14,337 crore and trades at 13.38 times earnings, while the industry P/E is 20.30.

Reported numbers show FY26 revenue of Rs 21,973 crore, up 28.4% year on year, with net profit at Rs 996 crore, up 50.5%. The June 2026 quarter added revenue of Rs 6,146 crore (up 35.4%) and net profit of Rs 393 crore (up 23.9%).

Return on equity is 14.69%, debt-to-equity is 1.02, and the dividend yield is 1.09%. Promoters hold 57.85%, foreign institutions 4.79% and domestic institutions 20.26% as of September 2026. Domestic institutional holding has risen from 12.99% to 20.26% over the last year. A point to keep in view: debt is higher than most names on this list.

SRF: The Diversified Chemicals Major Among Medium Term Stocks to Buy

SRF is a diversified maker of fluorochemicals, speciality chemicals, packaging films and technical textiles. Its market capitalisation is Rs 69,630 crore, the share price is Rs 2,429 and the P/E of 30.50 compares with an industry P/E of 33.45.

Over FY26, net profit rose 46.7% to Rs 1,835 crore on revenue of Rs 15,894 crore, which was up 7.2%. The latest quarter, the September 2026 quarter, brought revenue of Rs 4,929 crore, up 34.5% year on year, and net profit of Rs 509 crore, up 31.2%.

Return on equity is 14.92%, debt-to-equity is 0.35, and the dividend yield is 0.38%. Promoters hold 50.26%, foreign institutions 15.20% and domestic institutions 22.51% as of September 2026. Domestic institutional holding has risen from 19.53% to 22.51% over the last year.

Check Medium Term Stocks Live on the Univest Screener

Time Technoplast: The Industrial Polymer Maker Among Medium Term Stocks to Buy

Time Technoplast is a maker of industrial packaging, composite cylinders and other polymer products. The stock trades at Rs 166.50 with a market capitalisation of Rs 8,031 crore and a P/E of 16.12, against an industry P/E of 33.18.

FY26 revenue rose 11.9% to Rs 6,114 crore and net profit rose 20.8% to Rs 477 crore. In the June 2026 quarter, revenue grew 25.1% year on year to Rs 1,694 crore, while net profit grew 22.1% to Rs 118 crore.

Return on equity is 11.46%, debt-to-equity is 0.18, and the dividend yield is 0.92%. Promoters hold 47.47%, foreign institutions 9.16% and domestic institutions 17.85% as of September 2026. Domestic institutional holding has risen from 16.63% to 17.85% over the last year.

KEI Industries: The Power Cable Specialist Among Medium Term Stocks to Buy

KEI Industries is a maker of power cables, including extra-high-voltage cables, along with stainless steel wire. At Rs 3,881, the stock has a market capitalisation of Rs 36,843 crore and trades at 34.90 times earnings, while the industry P/E is 39.42.

Reported numbers show FY26 revenue of Rs 11,906 crore, up 21.4% year on year, with net profit at Rs 918 crore, up 31.9%. The September 2026 quarter added revenue of Rs 3,801 crore (up 37.3%) and net profit of Rs 262 crore (up 29.0%).

Return on equity is 14.66%, debt-to-equity is 0.05, and the dividend yield is 0.12%. Promoters hold 35.00%, foreign institutions 26.14% and domestic institutions 26.26% as of September 2026.

Rainbow Children's Medicare: The Paediatric Hospital Chain Among Medium Term Stocks to Buy

Rainbow Children's Medicare is a paediatric and maternity hospital chain. Its market capitalisation is Rs 12,168 crore, the share price is Rs 1,246 and the P/E of 41.92 compares with an industry P/E of 61.50.

Over FY26, net profit rose 15.3% to Rs 282 crore on revenue of Rs 1,747 crore, which was up 11.5%. The latest quarter, the June 2026 quarter, brought revenue of Rs 483 crore, up 29.4% year on year, and net profit of Rs 62.5 crore, up 16.2%.

Return on equity is 16.89%, debt-to-equity is 0.54, and the dividend yield is 0.29%. Promoters hold 49.83%, foreign institutions 14.66% and domestic institutions 23.28% as of September 2026. Domestic institutional holding has risen from 17.46% to 23.28% over the last year.

Download the Univest iOS App or Univest Android App to track these medium term stocks live and get daily stock recommendations.

Growth Snapshot: Latest Full Year and Latest Quarter

The table compares year-on-year growth in revenue and net profit for all five medium term stocks, using filed results.

Company	Full-Year Revenue Growth	Full-Year Profit Growth	Latest Quarter	Quarter Revenue Growth	Quarter Profit Growth
Paradeep Phosphates	28.4%	50.5%	Jun 2026	35.4%	23.9%
SRF	7.2%	46.7%	Sep 2026	34.5%	31.2%
Time Technoplast	11.9%	20.8%	Jun 2026	25.1%	22.1%
KEI Industries	21.4%	31.9%	Sep 2026	37.3%	29.0%
Rainbow Children's Medicare	11.5%	15.3%	Jun 2026	29.4%	16.2%

Factors That Move Medium Term Stocks to Buy

Four factors tend to drive medium term stocks, and each one is worth checking before a purchase.

• Steady growth: Several good quarters support a longer holding period.
• Valuation: A high P/E leaves less room for error.
• Sector drivers: Fertiliser, chemicals, cables and healthcare follow different cycles.
• Balance sheet: Moderate debt keeps the business flexible.

Risks to Keep in Mind Before Buying Medium Term Stocks

The first risk is that the five businesses follow different cycles, so a good quarter in one does not carry across the list. The second is valuation, because growth already shown in results may be partly reflected in prices. Review results every quarter.

On the numbers, Rainbow Children's Medicare trades at the highest P/E on this list at 41.92, so its earnings need to keep growing to support the price. Medium Term stocks to buy can still fall when markets turn weak, and a staggered entry has historically suited investors better than a lump-sum purchase.

How to Choose Medium Term Stocks to Buy

• Track results: Check profit and revenue each quarter.
• Review debt: Lower borrowings help in slow periods.
• Compare valuations: Look at P/E against the industry.
• Plan the exit: Decide in advance when you will review.

How to Invest in Medium Term Stocks

1. Shortlist two or three companies from this list that match your risk appetite.
2. Open the Univest Screener and compare P/E, ROE and debt for each stock.
3. Check the latest quarterly results and shareholding pattern on NSE or BSE.
4. Decide an amount you can hold for three to five years and split it into two or three purchases.
5. Review the holding after every quarterly result instead of reacting to daily price moves.

Conclusion

Paradeep Phosphates offers the lowest P/E on this list at 13.38, Rainbow Children's Medicare has the highest return on equity at 16.89%, and Paradeep Phosphates posted the fastest net profit growth in its latest full year at 50.5%. Among the best medium term stocks in India, these five give investors a spread of size, valuation and growth, so the right pick depends on risk appetite and holding period. Spread the entry, keep position sizes sensible and consult a SEBI-registered advisor before investing in any of these medium term stocks to buy.

Frequently Asked Questions on Medium Term Stocks to Buy

Which are the best medium term stocks to buy in November 2026?

Ans. The five medium term stocks on the November 2026 watchlist are Paradeep Phosphates, SRF, Time Technoplast, KEI Industries and Rainbow Children's Medicare. Paradeep Phosphates has the lowest P/E at 13.38, Rainbow Children's Medicare has the highest ROE at 16.89%, and Paradeep Phosphates grew net profit 50.5% in its latest full year. This is educational content, not investment advice, so please consult a SEBI-registered advisor.

Is SRF a good stock to buy from this Medium Term list?

Ans. SRF is the largest company on this list with a market capitalisation of Rs 69,630 crore and a P/E of 30.50 against an industry P/E of 33.45. Its FY26 revenue rose 7.2% and net profit rose 46.7%, with return on equity at 14.92%. Whether it suits you depends on your risk appetite and holding period, so please consult a SEBI-registered advisor before investing.

Are these medium term stocks expensive right now?

Ans. Valuations vary across the group. Paradeep Phosphates trades at a P/E of 13.38, SRF trades at a P/E of 30.50, Time Technoplast trades at a P/E of 16.12, KEI Industries trades at a P/E of 34.90, Rainbow Children's Medicare trades at a P/E of 41.92, against industry multiples ranging from 20.30 to 61.50. Higher multiples reflect faster growth but also leave less room for earnings misses, so entry price deserves attention.

Which of these medium term stocks pay a dividend?

Ans. Dividend yields on this list are Paradeep Phosphates 1.09%, SRF 0.38%, Time Technoplast 0.92%, KEI Industries 0.12%, Rainbow Children's Medicare 0.29%. Yields are modest across the group, so most investors look at these stocks for growth in earnings rather than for income, and payouts can change with company profits.

Which stock on this list has the highest return on equity?

Ans. Rainbow Children's Medicare has the highest ROE on this list at 16.89%, followed by SRF at 14.92% and Paradeep Phosphates at 14.69%. A higher ROE shows a company earns more profit on shareholder capital, but it should be read alongside valuation and debt.

What are the risks of investing in medium term stocks?

Ans. The main risks are business cycles that differ across sectors, growth already reflected in prices and quarter-to-quarter variation. On this list, Rainbow Children's Medicare trades at the highest P/E of 41.92, which leaves less room for earnings disappointments. Staggered buying and a long holding period can help manage these risks.

How can I invest in medium term stocks in India?

Ans. You can buy these stocks directly on NSE or BSE through a demat account, and compare them first on the Univest Screener using P/E, ROE and debt. Many investors split the amount across two or three purchases and review the holding after each quarterly result. Sector-themed mutual funds and ETFs are another route for investors who prefer diversification.